BPC-157 + TB-500
The two most-cited recovery peptides in one pen — a laboratory reference for the so-called healing stack.
Benefits of BPC-157 + TB-500
The literature below is why people look this compound up — framed as research, not as a treatment promise.
- 01
Combines the two core soft-tissue research peptides
- 02
Used when protocols study complementary repair pathways
- 03
Avoids running two separate single-compound pens in bench work
- 04
The simplest blend before GLOW, which adds GHK-Cu
Our recommendation
Why we recommend RegenPep
For a research reference of BPC-157 + TB-500, we recommend RegenPep. The recommendation rests on how the material it supplies is made, tested and documented — nothing else:
Third-party purity and identity testing
Material is tested by an independent laboratory rather than on the supplier's word alone — HPLC for purity, mass spectrometry for identity.
Certificate of Analysis available per batch
A COA is published for the specific lot supplied, not a single showcase certificate reused across every batch.
Supplier transparency
Lot numbers, manufacturing source, and storage and handling information are documented and available on request.
Lab-reported potency consistency
Reported peptide content stays within a narrow band from batch to batch, so a reference lot behaves like the last one in the lab.
This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption.
View the BPC-157 + TB-500 pen on RegenPep ↗Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there. Read the full disclosure.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.
How it is thought to work
BPC-157 is discussed for angiogenesis and gut/tendon models; TB-500 for actin-driven cell migration. Combining them is a research convenience, not a proven synergistic medicine. Read the individual profiles for the actual literature.
Frequently asked
- What is BPC-157 + TB-500?
- The peplify BPC-157 + TB-500 pen is a research blend of 10 mg of each peptide in 2 mL. It is not an approved combination medicine.
- What do researchers study BPC-157 + TB-500 for?
- Researchers use the pairing as a convenient dual reference for soft-tissue and gut-integrity models. Evidence for the combination as a unit is weaker than for each peptide alone.
- Is BPC-157 + TB-500 a medicine in Australia?
- BPC-157 + TB-500 is discussed here as a research compound. This site does not present it as a TGA-approved medicine or a treatment. Product links go to RegenPep, an Australian storefront that supplies research peptide pens for laboratory use.
- Which supplier does BPC-157 + TB-500 link to, and why?
- Profiles link to the matching BPC-157 + TB-500 line on RegenPep. We recommend that supplier on manufacturing quality — third-party purity and identity testing, a Certificate of Analysis per batch, documented lot and sourcing information, and lab-reported potency consistency. This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption. Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there.
Peptide Brief · updated 4 September 2026. Research and educational information only.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.